Skip to content

Surgical treatment outcomes in patients with different pulmonary diseases caused by Mycobacteria

Surgical treatment outcomes in patients with a diagnosis of nontuberculous mycobacterial pulmonary disease, a combination of nontuberculous mycobacterium pulmonary disease and pulmonary tuberculosis, or cavitary pulmonary tuberculosis: a retrospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN66445153
Enrollment
83
Registered
2021-11-17
Start date
2011-06-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical outcomes of patients with nontuberculous mycobacterial pulmonary disease, a combination of nontuberculous mycobacterium pulmonary disease and pulmonary tuberculosis, or cavitary pulmonary tuberculosis Surgery

Interventions

This study will investigate the outcomes of treatment in a cohort of patients admitted to hospital between January 2011 and December 2017, who underwent resectional lung surgery for nontuberculous myc

Sponsors

Sechenov University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Surgery performed at Sechenov University Phthisiopulmonology Clinical Hospital to treat one of the following: 1. Nontuberculous mycobacterial pulmonary disease between 2011 and 2021 2. A combination of nontuberculous mycobacterium pulmonary disease and pulmonary tuberculosis between 2011 and 2021 3. Cavitary pulmonary tuberculosis from 2016 to 2017

Exclusion criteria

Exclusion criteria: 1. Admitted before January 2011 and after December 2017 2. Received lung resections and/or do not have the nontuberculous mycobacterial pulmonary disease, a combination of nontuberculous mycobacterium lung disease and pulmonary tuberculosis, or cavitary pulmonary tuberculosis

Design outcomes

Primary

MeasureTime frame
1. Sputum culture conversion after surgery measured using microscopic examination (AFB smear); samples, which were cultured on Lowenstein–Jensen (L-J) medium and molecular diagnostic testing after surgery 2. 30 -day postoperative mortality rate measured using patient records at 30 days post-surgery 3. Intra- and postoperative complications measured using patient follow-up at 1, 3, and 5 years post-surgery 4. Postoperative mortality due to pulmonary disease and any other possible causes measured using patient follow-up at 1, 3, and 5 years post-surgery

Secondary

MeasureTime frame
1. Sputum culture conversion rate measured using microscopic examination (AFB smear); samples, which were cultured on Lowenstein–Jensen (L-J) medium and molecular diagnostic testing after surgery and at 1, 3, and 5 years post-surgery 2. Presence of cavities in pulmonary tissue (CV+/CV-) measured using CT scan/digital X-ray on discharge from hospital at 1, 3, and 5 years post-surgery 3. Five-year survival rate measured using patient follow-up at 5 years post-surgery

Countries

Russian Federation

Contacts

Public ContactLyudmila Severova
severova_l_p@staff.sechenov.ru+79037394349

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026